NDC Active Ingredient Belimumab

List of the 3 NDC products with the active ingredient Belimumab. This medication is used to treat a certain type of lupus, systemic lupus erythematosus, in patients who are receiving other lupus medicines. It works by binding to a protein (found in high levels in patients with active lupus) in the blood and limiting the activity of the protein. It helps decrease the symptoms of lupus. Belimumab is a type of medication called a monoclonal antibody.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
49401-088Benlysta BelimumabSolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
49401-101Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcHuman Prescription Drug
49401-102Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcHuman Prescription Drug